United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma Alfasigma acquisition of Zelnorm : Alfasigma USA, a subsidiary of Italian pharmaceutical company Alfasigma, has acquired IBS-C drug… bypharmanewsdailyJuly 8, 2019
